Novo Nordisk Aktie
41,37
EUR
+0,14
EUR
+0,33
%
41,20
EUR
-0,89
EUR
-2,11
%
Werbung
Novo Nordisk Aktie Analyse
| 16.01.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Novo Nordisk kaufen | Bernstein Research | |
| 21.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 18.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.11.19 | Novo Nordisk overweight | Barclays Capital | |
| 06.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 04.11.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 04.11.19 | Novo Nordisk Outperform | Bernstein Research | |
| 04.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.11.19 | Novo Nordisk buy | UBS AG | |
| 01.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 21.10.19 | Novo Nordisk buy | UBS AG | |
| 09.10.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 23.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.09.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.09.19 | Novo Nordisk Outperform | Bernstein Research | |
| 05.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.09.19 | Novo Nordisk buy | UBS AG | |
| 28.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.08.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 09.08.19 | Novo Nordisk buy | UBS AG | |
| 09.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 31.07.19 | Novo Nordisk buy | UBS AG | |
| 08.07.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.07.19 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 18.06.19 | Novo Nordisk buy | UBS AG | |
| 17.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.06.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 12.06.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.06.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 11.06.19 | Novo Nordisk buy | UBS AG | |
| 11.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.06.19 | Novo Nordisk Outperform | Bernstein Research | |
| 29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.05.19 | Novo Nordisk buy | UBS AG | |
| 06.05.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.05.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.05.19 | Novo Nordisk buy | UBS AG | |
Werbung
Werbung